Nervous system cancer models: Medulloblastoma

Drug Discovery Today: Disease Models

Volumn 3, Issue 2, 2006, Pages 167-174

  Hatton, Beryl A ^a,b   Pritchard, Joel I ^a,b   Olson, James M ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BUTYRIC ACID; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLOPAMINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; HISTONE DEACETYLASE INHIBITOR; ISOTRETINOIN; MONOCLONAL ANTIBODY; MYC PROTEIN; N [N (3,5 DIFLUOROPHENACETYL)ALANYL]PHENYLGLYCINE TERT BUTYL ESTER; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NOTCH RECEPTOR; ONCOPROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN INHIBITOR; PROTEIN KINASE B; PROTEIN P53; PROTEIN PATCHED 1; RETINOBLASTOMA PROTEIN; RETINOIC ACID; RETINOID; SOMATOMEDIN B; SOMATOMEDIN C RECEPTOR; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR OTX2; TRICHOSTATIN A; UNCLASSIFIED DRUG; UNINDEXED DRUG; VORINOSTAT;

ACCURACY; APOPTOSIS; CANCER CELL CULTURE; CANCER GENETICS; CANCER MODEL; CARCINOGENESIS; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM TUMOR; CHILDHOOD CANCER; DRUG TARGETING; GENE ACTIVITY; GENE MUTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MEDULLOBLASTOMA; MOUSE; NERVE CELL DIFFERENTIATION; NEUROSURGERY; NONHUMAN; NUCLEOTIDE SEQUENCE; REVIEW; SIGNAL TRANSDUCTION;

EID: 33747439435     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2006.05.007     Document Type: Review

References (32)

1. Hernan R., et al. ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma. Cancer Res. 63 (2003) 140-148
2. Sonnemann J., et al. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells. Int. J. Oncol. 28 (2006) 755-766
3. Berman D.M., et al. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 297 (2002) 1559-1561
4. Romer J., and Curran T. Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics. Cancer Res. 65 (2005) 4975-4978
5. Williams J.A., et al. Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Proc. Natl. Acad. Sci. U S A 100 (2003) 4616-4621
6. Chen J.K., et al. Small molecule modulation of Smoothened activity. Proc. Natl. Acad. Sci. U S A 99 (2002) 14071-14076
7. Hallahan A.R., et al. BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat. Med. 9 (2003) 1033-1038
8. Gumireddy K., et al. All-trans-retinoic acid-induced apoptosis in human medulloblastoma: activation of caspase-3/poly(ADP-ribose) polymerase 1 pathway. Clin. Cancer Res. 9 (2003) 4052-4059
9. Di C., et al. Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid. Cancer Res. 65 (2005) 919-924
10. Su X., et al. Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation. Mol. Cell Biol. 26 (2006) 1666-1678
11. Singh S.K., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63 (2003) 5821-5828
12. Singh S.K., et al. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
13. Lee A., et al. Isolation of neural stem cells from the postnatal cerebellum. Nat. Neurosci. 8 (2005) 723-729
14. Taylor M.D., et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8 (2005) 323-335
15. Goodrich L.V., et al. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277 (1997) 1109-1113
16. Sanchez P., and Ruiz i Altaba A. In vivo inhibition of endogenous brain tumors through systemic interference of Hedgehog signaling in mice. Mech. Dev. 122 (2005) 223-230
17. Romer J.T., et al. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell 6 (2004) 229-240
18. Weiner H.L., et al. Induction of medulloblastomas in mice by sonic hedgehog, independent of Gli1. Cancer Res. 62 (2002) 6385-6389
19. Rao G., et al. c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in mice. Neoplasia 5 (2003) 198-204
20. Hallahan A.R., et al. The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Res. 64 (2004) 7794-7800
21. Oliver T.G., et al. Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma. Development 132 (2005) 2425-2439
22. Wetmore C., et al. Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. Cancer Res. 61 (2001) 513-516
23. Lee Y., and McKinnon P.J. DNA ligase IV suppresses medulloblastoma formation. Cancer Res. 62 (2002) 6395-6399
24. Tong W.M., et al. Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) mice. Am. J. Pathol. 162 (2003) 343-352
25. Marino S., et al. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 14 (2000) 994-1004
26. Zindy F., et al. Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c/p53-null mice. Cancer Res. 63 (2003) 5420-5427
27. Uziel T., et al. The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation. Genes Dev. 19 (2005) 2656-2667
28. Pomeroy S.L., et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415 (2002) 436-442
29. Hartmann W., et al. Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells. Am. J. Pathol. 166 (2005) 1153-1162
30. Hahn H., et al. Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma. J. Biol. Chem. 275 (2000) 28341-28344
31. Rao G., et al. Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene 23 (2004) 6156-6162
32. Browd S.R., et al. N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma. Cancer Res. 66 (2006) 2666-2672